| Blake C Landry, MD | |
|
2365 Gause Blvd E Ste E, Slidell, LA 70461-4142 | |
| (985) 643-1194 | |
| (985) 643-8869 |
| Full Name | Blake C Landry |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 2365 Gause Blvd E Ste E, Slidell, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417953597 | NPI | - | NPPES |
| 720847461 0009 | Other | LA | CIGNA |
| 153236130118 | Other | LA | HUMANA |
| 0005507718 | Other | LA | AETNA |
| 1494895 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 022661 (Louisiana) | Secondary |
| 174400000X | Specialist | 022661 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Slidell Memorial Hospital | Slidell, LA | Hospital |
| Entity Name | Obhg Louisiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639567316 PECOS PAC ID: 9234443250 Enrollment ID: O20150805006718 |
News Archive
A new study adds to the sum of knowledge about SARS-CoV-2, with respect to its natural and biologically significant mutations, using computational modeling of the virus-receptor interactions. Understanding how viral mutations affect the virus-host interactions is crucial for shaping proper strategies to control the virus.
According to a newly released study students can look forward to more than just gaining knowledge when they go to college; they will also it seems, gain as much as 15 pounds or more in that first semester.
A study published in the January 13, 2010 issue of the Journal of Neuroscience links a loss of smell function in Alzheimer's disease (AD) model animals with amyloid β (protein) accumulation in the brain, a distinguishing hallmark of Alzheimer's disease. Research conducted by NYU Langone Medical Center suggests that olfactory dysfunction, a common symptom of AD, may serve as an early diagnostic tool for the disease.
UT Dallas researchers have demonstrated that treating tinnitus, or ringing in the ears, using vagus nerve stimulation-tone therapy is safe and brought significant improvement to some of the participants in a small clinical trial.
Covidien, a leading global provider of healthcare products, today announced that the Solitaire™ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Blake C Landry, MD 2365 Gause Blvd E Ste E, Slidell, LA 70461-4142 Ph: (985) 643-1194 | Blake C Landry, MD 2365 Gause Blvd E Ste E, Slidell, LA 70461-4142 Ph: (985) 643-1194 |
News Archive
A new study adds to the sum of knowledge about SARS-CoV-2, with respect to its natural and biologically significant mutations, using computational modeling of the virus-receptor interactions. Understanding how viral mutations affect the virus-host interactions is crucial for shaping proper strategies to control the virus.
According to a newly released study students can look forward to more than just gaining knowledge when they go to college; they will also it seems, gain as much as 15 pounds or more in that first semester.
A study published in the January 13, 2010 issue of the Journal of Neuroscience links a loss of smell function in Alzheimer's disease (AD) model animals with amyloid β (protein) accumulation in the brain, a distinguishing hallmark of Alzheimer's disease. Research conducted by NYU Langone Medical Center suggests that olfactory dysfunction, a common symptom of AD, may serve as an early diagnostic tool for the disease.
UT Dallas researchers have demonstrated that treating tinnitus, or ringing in the ears, using vagus nerve stimulation-tone therapy is safe and brought significant improvement to some of the participants in a small clinical trial.
Covidien, a leading global provider of healthcare products, today announced that the Solitaire™ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial.
› Verified 1 days ago